Reliance on Independent/Central IRBs for Multicenter Clinical Trials

Similar documents
RESEARCH PROTECTIONS OFFICE

Single IRB Review. Jeannie Barone Director, HRPO. Institutional Review Board

Commercial/ Central IRB An independent organization that provides IRB review services

IRBMED: Ceding IRB Review to an External IRB

University of Pennsylvania Institutional Review Board. Reliance Agreement Guidance: Penn as Central IRB FAQ

SMART IRB Agreement Implementation Checklist and Documentation Tool

IRB Reliance Models: Workshop for OSU Researchers Collaborating with External Partners

November 30, Efficient Startup of Multi-site Research Studies: Central IRBs and National IRB Reliance Platforms

Florida State University IRB Standard Operational Procedures

University of Iowa External/Central IRB Reliance Process Standard Operating Procedure (SOP)

UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONTINUING REVIEW AND REAPPROVAL OF RESEARCH

Ceded IRB Review. The University of Arizona has standing agreements in place for the following entities regarding ceded IRB review:

IRB Authorization Agreement Implementation Checklist and Documentation Tool

University of Pennsylvania Institutional Review Board. Reliance Agreement Guidance: How to Apply for External IRB Review

Independent Ethics Committees

UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER INSTITUTIONAL REVIEW BOARD CONTINUING REVIEW OF RESEARCH

Centralized IRB Models

OHRP Guidance on Written IRB Procedures

Ceded IRB Review. The project involves prisoners or other vulnerable populations that require special considerations.

Institutional Review Board Submission Requirement Presentation

Your Roadmap to Single IRB Review Serving as a Reviewing IRB

HEALTH CARE SYSTEMS RESEARCH NETWORK

Pepperdine University eprotocol - IRB Student Investigator User Guide

Submitting Continuing Reviews and/or Amendments to the IRB

Signature Date Date First Effective: Signature Date Revision Date:

UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD PROCEDURES FOR FULL BOARD REVIEW

AUTHORITY AND PURPOSE

Effective Date: January 16, 2012 Policy Number: Appendix II. Revised Date: November 2, 2015 Oversight Level: Corporate

Click IRB Resources Frequently Asked Questions

CONTINUING REVIEW CRITERIA FOR RENEWAL

Info Sheet - Operations Office for Human Research Studies

Central IRBs: Where Does the UR Fit into the Picture?? Kelley O Donoghue Tiffany Gommel Emily Flagg April 15 th 2015

Human Subjects in Research Review and Monitoring Form. Not applicable

Initial Review. Approved By: Michele Kennett, JD, MSN, LLM Associate Vice Chancellor for Research. Table of Contents

INTRA-INSTITUTIONAL COMMUNICATION

SOP 5.06 Full Committee Review: Initial IRB Review

Frequently Asked Questions (FAQs)

A Guide to SMART IRB s Resources for IRB and HRPP Personnel

IRB Minutes Quality Improvement Assessment

The Children s Hospital of Philadelphia Committee for the Protection of Human Subjects Policies and Procedures. Cooperative Agreements

University of Iowa External/Central IRB Single IRB (sirb) Reliance Process Standard Operating Procedure (SOP)

Institutional Review Board Standard Operating Procedure. Suspension and Termination of IRB Approval

CONTINUING REVIEW CRITERIA FOR RENEWAL

Effective Date: January 16, 2012 Policy Number: MHC_RP0107. Revised Date: November 2, 2015 Oversight Level: Corporate

THE DUHS IRB REVIEW PROCESS 8/13/2014

CONTINUING REVIEW 3/7/2016

PRINCIPAL INVESTIGATOR S ACKNOWLEDGMENT OF RESPONSIBILITIES

CONTINUING REVIEW OF APPROVED IRB PROTOCOLS

RESEARCH SUBMISSION REQUIREMENTS

I. Summary. II. Responsibilities

IRB Chair Responsibilities

UNIVERSITY OF GEORGIA Institutional Review Board

What s New in GCP? FDA, OHRP Issue Harmonized Guidance on Transferring IRB Oversight of Clinical Studies

GUIDE TO DAILY OPERATIONS

Screening and Enrollment Log. List of all subjects screened and all subjects screened and enrolled in the study.

FDA s Guidance on Using a Centralized IRB Review Process in Multicenter Clinical Trials

Yale University Human Research Protection Program

SYRACUSE UNIVERSITY HUMAN RESEARCH PROTECTION PROGRAM STANDARD OPERATING PROCEDURES 02 06/30/10 08/01/07 1 OF 6

External IRB Instructions for the Registration Pathway in OSIRIS

HOW TO CONDUCT AN IRB RELIANCE AGREEMENT. What Reliance Agreements Are, How They Are Reviewed, and What It Means for Submitting Research

Institutional Responsibilities Under A Federalwide Assurance

Cayuse IRB Policy and Procedure Manual

The IRB reviews and monitors human subjects research conducted by Columbia College Chicago faculty, staff, and students.

Children s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures Continuing Review of Approved Research

Signature Date Date First Effective: Signature Date Revision Date: 07/18/2011

Quick Reference Manual For New DUHS IRB Members

Title: EXPEDITED IRB REVIEW OF HUMAN SUBJECTS RESEARCH

Administrative Hold, Suspension, or Termination of IRB Approval

Yale University Institutional Review Boards

Obtaining IRB Approval: The eirb Application Process

Review of Research by the Convened IRB

INSTITUTIONAL REVIEW BOARD (IRB) PROCEDURES

IRB-REQUIRED INVESTIGATOR ACTIONS

Children s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures. IRB Review Processes

INSTITUTIONAL REVIEW BOARD MANUAL: PURPOSE and POLICIES.

University of Pennsylvania Institutional Review Board. Reliance Agreement Guidance: Post-Approval Submissions

SOP 801: Investigator Qualifications and Responsibilities

IRB MEMBERSHIP COMPOSITION, ROLES AND RESPONSIBILIES

Research Involving Human Subjects: AA 110.7

POLICY NO EXEMPT RESEARCH... 4 POLICY NO DISCLOSURE OF RESEARCH LAB TEST RESULTS... 5

1. Review and approval of the consent document is a responsibility that FDA assigns to the IRB with jurisdiction

EMERGENCY USE 03/02/2016

THE UNIVERSITY OF SOUTH DAKOTA -- INSTITUTIONAL REVIEW BOARD -- STANDARD OPERATING PROCEDURES

Policy Number: 42 Title: Investigational Devices Date of Last Revision: 06/12/2008; 07/22/2010; 05/29/2013; 05/01/2016; 10/16/2018

Process of IRB Submissions

Lapse in IRB Approval

IV. Basic Procedures for Human Research Protections

Institutional Review Board (IRB) Policies and Procedures Manual

Chapter 4 Institutional Review Board (IRB) Roles and Authorities

IRB MEETING ADMINISTRATION

Illinois Institute of Technology Institutional Review Board Handbook of Procedures for the Protection of Human Research Subjects

Investigator Manual. If you have questions about whether an activity requires IRB review, contact the IRB Office.

Your Roadmap to Single IRB Review Getting Started with SMART IRB & the Online Reliance System

SOP 407: PROTOCOL DEVIATIONS AND UNANTICIPATED PROBLEMS

Guidance for IRBs, Clinical Investigators, and Sponsors IRB Continuing Review after Clinical Investigation Approval

COMPLIANCE MONITORING

WSU IRB. Policies and Procedures

Study Management SM STANDARD OPERATING PROCEDURE FOR Interactions with the Institutional Review Board (IRB)

Policies & Standard Operating Procedures

Procedure Department: HUMAN RESEARCH PROTECTIONS PROGRAM Policy Number: II.B.1

Transcription:

Reliance on Independent/Central IRBs for Multicenter Clinical Trials October 15, 2013

Outline Background New policy and process Non-IRB reviews Revised fee structure Workflow Demo of IRBIS application items Q&A

Background Academic institutions increasingly relying on independent IRBs Sole provider model employed by most centers has its own drawbacks Few data to guide decisions In 2012-13, UNC conducted novel pilot project Randomized, controlled comparison of local vs central IRB review Assessed feasibility and acceptability of relying on any central/independent/commercial IRB already involved with a multicenter trial, provided certain criteria were met

Pilot Project Results Quality of review by central IRBs was good Time savings of ~20 days per trial, if master service agreements already in place Little advantage if no standing agreement 8 central IRBs utilized for 22 protocols randomized to the experimental arm Reinforced our hypothesis that sole provider model misses many opportunities to streamline Data supported informed policy change

New Policy and Process Effective October 15, 2013, UNC will rely on the approval and oversight of the central/independent IRB already involved with an industry-sponsored, multicenter trial, provided certain criteria are met Sponsor/CRO has contracted with independent IRB to provide central review for any/all sites in that study IRB is on UNC s pre-approved list

Which IRBs? Alpha IRB Aspire IRB Chesapeake IRB Compass IRB Copernicus IRB Ethical & Independent IRB IntegReview IRB IRB Company IRB Service, LTD Quorum IRB Schulman and Associates Sterling WIRB Additional IRBs may be added over time, on request.

What is this NOT? Use of central IRB under these circumstances is allowed, encouraged, should be desirable but is NOT mandatory You still have the option to use UNC IRB This is NOT a mechanism to involve a commercial IRB in homegrown single site studies in which that IRB is not already involved These will remain under UNC IRB oversight

Your interaction with central IRB will shift from protocol review to site registration (think add personnel ) Protocol Non-IRB Issues Personnel & Facilities Sponsor/CRO Protocol Site Site Site Site UNC IRB Site Central IRB

Important to Realize Even when IRB review is outsourced UNC is still responsible There are other University-based reviews and obligations that are not transferred to central IRB, and must still be satisfied HIPAA Conflict of Interest (COI) Investigational Drug Service (IDS) Radiation safety Institutional biosafety Data security Institutional consent language congruence with CTA OHRE and IRBIS will remain central relay station

Revised Fee Structure Industry-Funded Multisite Clinical Trials WITH Central IRB IRB Preparation Fee - $1,000 All Other Industry-Funded Clinical Trials IRB Preparation & Review Fee - $3,000 IRB Renewal Fee - $750

Workflow Submit IRB application requesting reliance on Independent IRB Receive IRB stipulation letter with permission to use Independent IRB & CF injury language Register site with Independent IRB Satisfy all Independent IRB & UNC requirements Respond to UNC IRB stipulation letter Receive UNC reliance letter documenting permission to begin study

The vast majority of IRBIS application questions have been suppressed Approx 10-20 questions remain, depending on circumstances of individual study

Abbreviated IRBIS Application Section Questions Purpose Served General Info Personnel, Sponsor, Multisite? COI, training, REQUEST RELIANCE ON CENTRAL IRB A.4.A.2 Biomedical- drugs, devices? IDS A.4.A.3 Stem cells, clinical labs, radiation, gene transfer? A.9 Identifiers? Data security A.10 Confidentiality, sensitivity? Data security ESCRO, UNC-HCS, RSC, IBC B.2 Protected Health Info (PHI)? HIPAA waiver or authorization B.4 Collecting SSN for payments? SSN collection form C.4 Sources of data? Data security

Demo of IRBIS Application for Central IRB Scenarios

IMPORTANT: YOU MUST RESPOND YES SCREENING QUESTION #6

Insert screen shots from Jack, selecting Independent IRB, showing dropdown menu

Select IRB from dropdown menu

Information used to determine data security level

Request limited waiver of HIPAA Triggers HIPAA authorization form

Triggers SSN collection form

2. Do not upload consent form until AFTER your site (and all site documents) have been approved 1. Generate HIPAA Authorization and SSN forms

EXCEPTIONS: You may check Not Yet Available/Not Applicable for Master Protocol, Investigator Brochure, Certificate of Confidentiality

Example of central IRB instructions on next slide UNC IRB Permission /stipulation letter (page 1)

UNC COI Information letter is emailed directly to each member of the research team who identified an external relationship with the study sponsor.

FINAL STEPS: Respond to IRB stipulations Upload current Central IRB approved consent form Upload a copy of the Central IRB approval letter Upload any outstanding attachments (i.e., institutional approvals) Click Proceed to Submit

RE: Agreement to Rely on External IRB External Organization: [External IRB] Study #: [IRB_ID] Study Title: [TITLE] This confirms that an IRB Authorization Agreement with the organization identified above has been executed to rely on their IRB for continuing oversight of this study. This agreement specifies the roles and responsibilities of the respective entities. [DESCRIPTION] [SUBMISSION_DESCRIPTION] It is your responsibility to: Inform the UNC IRB about any actions by the external IRB affecting their approval to conduct the study, including suspension or termination of approval. Submit a modification to the UNC IRB (via IRBIS) if/when new personnel are to added the study team or the study is modified in such a way that additional institutional approvals are required (e.g., radiation safety, biosafety). Submit a copy of the external IRB approval letter and current approved consent document to the UNC IRB (via IRBIS) when the study is renewed; you will continue to receive reminder notices from the UNC IRB for renewal, and should provide external approvals at that time. Report all Unanticipated Problems to the UNC IRB in addition to the external IRB Maintain compliance with all other UNC policies (e.g., data security, Investigational Drug Service (IDS), conflict of interest)